En Es
Categories

Industry News

GE Launches Drawbridge Health to Transform Blood Collection

By Labmedica International staff writers
05 Dec 2017

Image: GE’s new Drawbridge solution will eliminate the need for phlebotomy and travel to blood draw centers (Photo courtesy of iStock).GE Healthcare (Chicago, IL, USA) has introduced Drawbridge Health, a privately held healthcare technology company, which is developing a people-friendly system to integrate draw, collection and stabilize blood samples into a single device. The technology which integrates engineering and proprietary chemistries is also being developed to support room temperature shipping and streamlined downstream processing, thus ensuring reliable, accurate results.

The Drawbridge solution will allow healthcare providers and diagnostic testing companies to deliver a superior patient experience by eliminating the need for phlebotomy and travel to blood draw centers. Drawbridge expects its blood draw solution to alter the market for patients and healthcare providers by broadening the availability and access for molecular tests for a variety of diseases, as well as providing a convenient way to monitor overall health, therapy response and disease progression.

“At GE we share technology, markets, structure and knowledge across our varied businesses, which uniquely positions us to tackle many issues, including this one,” said Risa Stack, Managing Director of New Business Creation, GE Ventures. “With Drawbridge Health, we are combining technology from GE Global Research, expertise from GE Healthcare and business models from GE Ventures to offer a simple, safe and more efficient solution that can help save time, money and lives.”

“At Drawbridge Health, we have a tremendous opportunity to uniquely enable not only effortless access to diagnostic testing, but to also transform how diagnostics companies and healthcare providers interact with their patient-consumers,” said Lee McCracken, CEO, Drawbridge Health.

“The current sample testing process is inconvenient and challenging for patients and medical providers, alike. It requires clinical processing equipment, often a technician specifically trained to draw blood, plus a trip to the doctor’s office or hospital. By combining world class GE technology and a talented founding team to address an important market need, Drawbridge Health is well positioned to transform diagnostic testing for healthcare stakeholders, testing laboratories, patients and consumers.”



E-mail Print
FaceBook Twitter Google+ Linked in

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services. The company’s product areas include anesthesia delivery, diagnostic ECG, mammography, radiography, surgical imaging, maternal-infant care and clinical consumables.
More info

More articles about GE Healthcare

18 Oct 2018
GE Healthcare and ESR Enter AI Partnership for ECR 2019
GE Healthcare (Chicago, IL, USA) and the European Society of Radiology (Vienna, Austria) will be partnering on artificial intelligence (AI) for the upcoming European Congress of Radiology (ECR) to be held in Vienna, Austria on February 27-March 3, 2019. The partnership will include joint sessions on AI and a dedicated space at GE Healthcare’s booth where visitors will be able to experience the AI transformation through interactive tools.
Read More
15 Oct 2018
GE Healthcare to Implement First AI-Powered Hospital Command Centers
GE Healthcare is collaborating with hospital service providers in Europe and the US for implementing an artificial intelligence (AI)-powered command center to effectively and efficiently synchronize all elements of a patient's hospital experience. The AI-powered system will support caregivers to enhance patient safety, orchestrate seamless care delivery and get patients back home sooner.
Read More
26 Jun 2018
GE to Spin Off Healthcare Business
In line with a sweeping strategic reorganization, General Electric Company has announced the decision to spin off its Healthcare business segment as an independent company. The move comes on the heels of a lengthy managerial review conducted by GE management under newly appointed CEO John Flannery.
Read More
16 Jan 2018
GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
GE Healthcare and Roche have entered into a strategic, long-term partnership to jointly develop and co-market digital clinical decision support solutions. Initially, the partnership will focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.
Read More
06 Dec 2017
GE Healthcare and Nuance Partner with NVIDIA to Bring AI to Medical Imaging
Healthcare-solution providers GE Healthcare and Nuance Communications, Inc., have partnered with NVIDIA, a leader in visual computing technologies, for using the company’s deep learning platform to bring Artificial Intelligence (AI) to medical imaging.
Read More
28 Nov 2017
Global Surgical Imaging Market to Reach USD 1.63 Billion by 2022
The global surgical imaging market is projected to grow at a CAGR of 5.5% from an estimated value of USD 1.25 billion in 2017 to USD 1.63 billion by 2022, driven mainly by the growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to the advantages of FPDs over image intensifiers, reimbursement cuts on analog radiography systems, and rising demand for minimally invasive procedures.
Read More
28 Nov 2017
GE Healthcare and DiA Imaging Analysis to Develop Machine Learning Algorithms
GE Healthcare has entered into a multi-year, non-exclusive licensing and professional services agreement with DiA Imaging Analysis, a medical imaging analysis software company, for developing automated imaging analysis technology to work with its ultrasound devices.
Read More
16 Oct 2017
Handheld Scanners Market to Reach USD 725 Million by 2027
The global handheld ultrasound scanners market is projected to grow at a robust CAGR of 8.8% from around USD 311 million in 2017 to about USD 725 million by 2027 end, driven mainly by the increasing use of handheld ultrasound scanners among non-radiologists and modernization in healthcare, coupled with high investment in research and development (R&D).
Read More

Additional news

08 Jan 2019
New AI Technology Pinpoints Negative Symptoms in Cancer Patients
Researchers from the University of Surrey and the University of California have developed a new artificial intelligence (AI) tool, which can predict symptoms and their severity throughout the course of a cancer patient's treatment.
Read More
08 Jan 2019
Luminex Acquires MilliporeSigma Flow Cytometry Portfolio
Luminex Corporation has completed its previously announced acquisition of MilliporeSigma's flow cytometry portfolio.
Read More
31 Dec 2018
Deep Learning Technique Could Reveal Transparent Features in Medical Images
Engineers at the Massachusetts Institute of Technology have developed a deep learning technique that can reveal images of transparent features or objects that are nearly impossible to decipher in almost total darkness.
Read More
31 Dec 2018
Next-Gen Products Driving Global POC Molecular Diagnostics Market
The global point of care (POC) molecular diagnostics market is expected to grow at a CAGR of close to 14% during the period 2019-2023, driven mainly by the growing number of M&As and collaborations, and rising focus on next-generation products.
Read More
31 Dec 2018
Increased Breast Cancer Driving Global Digital Breast Tomosynthesis Market
The global digital breast tomosynthesis market is expected to grow at a CAGR of around 13% for the period 2019-2023, driven by the increasing incidence of breast cancer, growing popularity of digital breast tomosynthesis and consistent launch of new products.
Read More
31 Dec 2018
Global Urinalysis Market to Reach USD 1.5 Billion by 2024
The global urinalysis market is expected to grow at a steady CAGR of 5.40% over the 2016-2024 period to reach a value of USD 1.5 billion by the end of 2024, propelled mainly by the rising incidence of diabetes and urinal infections, globally.
Read More
31 Dec 2018
Bruker Completes Acquisition of Alicona Imaging
Bruker Corporation has completed its previously announced acquisition of Alicona Imaging GmbH, a provider of optical-based metrology products.
Read More
25 Dec 2018
New AI-Based Solutions Create Possibility for Early Cancer Screening
Two new Artificial Intelligence- (AI) based products released at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, USA, could create possibility for large-scale early cancer screening globally.
Read More
25 Dec 2018
Network-Based AI Engine Performs Airway Segmentation from CT Images
A new 2.5D convolutional neural network (CNN)-based artificial intelligence (AI) engine enables accurate airway segmentation from computed tomography (CT) images without any human interaction.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions